NCT02242760 - P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

213

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions

Acne Vulgaris

Interventions

DRUG

SB204 2%

Applied topically twice daily

DRUG

SB204 4%

Applied topically daily

DRUG

Vehicle Gel

Applied topically twice and once daily

Trial Locations (20)

10155

QST Site #107, New York

11790

QST Site #104, Stony Brook

14623

QST Site #108, Rochester

14625

QST Site #109, Rochester

23507

QST Site #114, Norfolk

24501

QST #105, Lynchburg

33486

QST Site #103, Boca Raton

33781

QST Site # 110, Pinellas Park

40202

QST Site #117, Louisville

48088

QST Site #120, Warren

48202

QST Site #112, Detroit

55432

QST Site # 121, Minneapolis

71913

Qst acne site #1, Hot Springs

78229

QST Site # 102, San Antonio

84117

QST Site #106, Salt Lake City

90404

QST Site #119, Santa Monica

92024

QST Site #118, Encinitas

92123

QST Site #111, San Diego

QST Site #113, San Diego

302636

QST Site # 116, Newnan

All Listed Sponsors

lead

Novan, Inc.

INDUSTRY